Topical 0.2% Loteprednol Etabonate vs. Topical 0.1% Dexamethasone in Impending Recurrent Pterygium

NCT04075227 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

108

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Pterygium of Eye
Steroid-Induced Glaucoma

Interventions

DRUG: 0.2% loteprednol etabonate
DRUG: 0.1% dexamethasone

Sponsor

Wannisa Suphachearabhan

Collaborators

[object Object]